Tumorigenicity assay indicated that HOTAIRM1 downregulation of transformed fibroblasts led to obvious decrease in both tumor volume and weight of subcutaneous implanted HOTAIRM1 knocking-down t-FB1/2 cells decreased obviously, compared with the control group (Figures 2K–P). Here, HOTAIRM1 is linked to neoplasm.